Fewer High-Risk GI Cancers Diagnosed During COVID-19 Pandemic
High-risk GI cancers were diagnosed substantially less during the COVID-19 pandemic, resulting in 3000 fewer diagnoses.
Stay updated with breaking news from Surgeons Cancer Programs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
High-risk GI cancers were diagnosed substantially less during the COVID-19 pandemic, resulting in 3000 fewer diagnoses.
Study findings suggest stay-at-home orders delayed cancer diagnoses
Study findings suggest stay-at-home orders delayed cancer diagnoses
During the first year of the COVID pandemic, as people were stuck at home and were less likely to visit their primary doctors for preventative care, a study found that new cancer diagnoses were 14.4% lower than in past years, a study has found. Published in JAMA Network, the study was led by Loma Linda
Amid stay-at-home orders early in the pandemic, some 200,000 people who had cancer did not receive diagnoses or treatment when the pandemic began in 2020, researchers found.